AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 29.8 |
Market Cap | 639.83M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 2.83 |
PE Ratio (ttm) | 11.86 |
Forward PE | n/a |
Analyst | Hold |
Ask | 34.25 |
Volume | 72,295 |
Avg. Volume (20D) | 102,237 |
Open | 34.10 |
Previous Close | 34.01 |
Day's Range | 33.11 - 34.25 |
52-Week Range | 31.44 - 52.75 |
Beta | undefined |
About USNA
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; a...
Analyst Forecast
According to 1 analyst ratings, the average rating for USNA stock is "Hold." The 12-month stock price forecast is $38, which is an increase of 13.20% from the latest price.
Next Earnings Release
Analysts project revenue of $215.48M, reflecting a -2.53% YoY shrinking and earnings per share of 0.61, making a -29.89% decrease YoY.
3 weeks ago · businesswire.com
USANA Health Sciences Announces Strategic Acquisition of Hiya HealthSALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) (the “Company,” “USANA”), today announced its acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC ...
2 months ago · seekingalpha.com
USANA Health Sciences, Inc. (USNA) Q3 2024 Earnings Call TranscriptUSANA Health Sciences, Inc. (NYSE:USNA ) Q3 2024 Earnings Call Transcript October 23, 2024 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Douglas Hekking - CFO Brent...